Sand Hill Global Advisors LLC held its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 534 shares of the medical equipment provider’s stock at the close of the 2nd quarter. Sand Hill Global Advisors LLC’s holdings in Intuitive Surgical were worth $499,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of ISRG. Guardian Life Insurance Co. of America raised its holdings in shares of Intuitive Surgical by 2.2% in the 1st quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after purchasing an additional 3 shares in the last quarter. D. Scott Neal Inc. bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $120,000. Parallel Advisors LLC raised its holdings in shares of Intuitive Surgical by 10.1% in the 1st quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after purchasing an additional 14 shares in the last quarter. Oppenheimer Asset Management Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $190,000. Finally, Aureus Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $205,000. Institutional investors and hedge funds own 94.23% of the company’s stock.
In other news, CEO Gary S. Guthart sold 17,975 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the transaction, the chief executive officer now directly owns 101,798 shares in the company, valued at $95,412,211.46. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Salvatore Brogna sold 899 shares of the firm’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $1,001.90, for a total transaction of $900,708.10. Following the transaction, the executive vice president now owns 570 shares in the company, valued at $571,083. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,172 shares of company stock worth $21,923,487. Insiders own 2.20% of the company’s stock.
Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down 0.04% during mid-day trading on Friday, reaching $1040.08. 147,866 shares of the company’s stock traded hands. The stock has a market capitalization of $38.64 billion, a PE ratio of 49.82 and a beta of 0.38. The stock’s 50 day moving average is $981.30 and its 200-day moving average is $882.57. Intuitive Surgical, Inc. has a 52 week low of $610.71 and a 52 week high of $1,054.77. Intuitive Surgical’s stock is going to split before the market opens on Friday, October 6th. The 3-1 split was announced on Friday, August 11th. The newly created shares will be payable to shareholders after the closing bell on Thursday, October 5th.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.05. The company had revenue of $756.20 million for the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter last year, the company earned $1.87 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post $23.92 EPS for the current year.
Several equities research analysts have recently commented on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $341.33 price target for the company in a report on Wednesday, May 31st. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Barclays PLC boosted their price target on shares of Intuitive Surgical from $290.00 to $333.33 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Morgan Stanley restated an “overweight” rating and issued a $356.67 price target (up previously from $316.67) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Finally, Vetr upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $340.77 price objective for the company in a research note on Monday, August 28th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $366.12.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with our FREE daily email newsletter.